II
DYN icon

Inspire Investing’s Dyne Therapeutics DYN Stock Holding History

Inspire Investing’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4K Sell
468
-8,835
-95% -$164K ﹤0.01% 1116
2026
Q1 		$169K Buy
+9,303
New +$160K 0.01% 888
2023
Q2 		– Sell
-39,722
Closed -$458K – 800
2023
Q1 		$458K Buy
+39,722
New +$516K 0.06% 253

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Inspire Investing's DYN Position: Q2 2026 in Review

Inspire Investing reduced its Dyne Therapeutics (DYN) stake by 95% in Q2 2026, selling an estimated $164K and leaving 468 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1116.

Inspire Investing first reported a position in DYN in Q1 2023 and has held it in 3 quarters since. The position peaked at $458K in Q1 2023. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Inspire Investing held 468 shares of Dyne Therapeutics worth $10.4K as of Q2 2026.
  • Inspire Investing sold 8,835 Dyne Therapeutics shares in Q2 2026, an estimated $164K.
  • Dyne Therapeutics made up ﹤0.01% of Inspire Investing's portfolio in Q2 2026, its #1116 holding.
  • Inspire Investing first reported a position in Dyne Therapeutics in Q1 2023 and has held it in 3 quarters since.
  • Inspire Investing's Dyne Therapeutics position peaked at $458K in Q1 2023.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.